XML 109 R92.htm IDEA: XBRL DOCUMENT v3.22.0.1
Schedule II. Condensed Financial Information of Registrant (Condensed Statements of Cash Flows) (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Operating activities      
Net income $ 119.3 $ 119.8 $ 157.1
Adjustments to reconcile net income to net cash provided by (used in) operating activities:      
Realized gains on investments (54.6) (19.0) (51.1)
Stock-based compensation 9.1 9.7 10.1
Amortization of premium on investments, net 8.5 9.8 8.7
Deferred income tax expense 6.7 (0.4) 8.6
Change in operating assets and liabilities:      
Accounts payable, accrued expenses and other liabilities (2.5) (4.0) (8.1)
Federal income taxes (7.9) 22.0 (7.4)
Other 6.3 (1.0) (11.8)
Net cash provided by (used in) operating activities 10.8 33.0 122.5
Investing activities      
Purchases of fixed maturity securities (516.6) (645.6) (359.0)
Purchase of equity securities (199.5) (179.5) (240.8)
Proceeds from sale of equity securities 135.9 243.4 232.4
Purchases of short-term investments (12.5) (135.9) 0.0
Proceeds from sale of fixed maturity securities 206.7 349.5 163.0
Proceeds from maturities and redemptions of fixed maturity securities 373.5 359.2 309.9
Net change in unsettled investment purchases and sales 3.4 (3.6) (24.7)
Net cash (used in) provided by investing activities (1.7) 84.3 49.2
Financing activities      
Acquisition of common stock (42.6) (99.4) (67.5)
Cash transactions related to stock-based compensation (2.7) (1.8) (2.5)
Dividends paid to stockholders and eligible equity plan holders (29.0) (30.5) (28.3)
Net cash used in financing activities (94.4) (111.9) (118.5)
Cash and cash equivalents at the beginning of the period 160.4    
Cash and cash equivalents at the end of the period 75.1 160.4  
Parent Company [Member]      
Operating activities      
Net income 119.3 119.8 157.1
Adjustments to reconcile net income to net cash provided by (used in) operating activities:      
Equity in net income of subsidiaries 40.9 39.9 70.4
Realized gains on investments 0.2 1.9 (3.3)
Stock-based compensation 9.1 9.7 10.1
Amortization of premium on investments, net 0.1 0.1 0.0
Deferred income tax expense (0.2) 0.8 (2.8)
Change in operating assets and liabilities:      
Accounts payable, accrued expenses and other liabilities 0.0 (2.2) 2.3
Federal income taxes (0.7) 3.5 19.2
Other assets 0.4 0.5 0.7
Intercompany payable/receivable (0.1) 3.5 (3.2)
Other 0.1 0.3 0.0
Net cash provided by (used in) operating activities 86.3 96.4 108.3
Investing activities      
Purchases of fixed maturity securities 0.0 (3.2) (9.3)
Purchase of equity securities (35.0) (3.0) (42.0)
Proceeds from sale of equity securities 10.3 29.0 56.0
Purchases of short-term investments 0.0 0.0 0.0
Proceeds from sale of fixed maturity securities 0.4 14.9 4.3
Proceeds from maturities and redemptions of fixed maturity securities 0.0 3.8 3.8
Proceeds from maturities of short-term investments 0.0 0.0 25.0
Net change in unsettled investment purchases and sales 5.8 (4.4) (5.0)
Capital Contributions to subsidiary 0.0 (0.4) (73.6)
Net cash (used in) provided by investing activities (18.5) 36.7 (40.8)
Financing activities      
Acquisition of common stock (42.6) (99.4) (67.5)
Cash transactions related to stock-based compensation (2.7) (1.8) (2.5)
Dividends paid to stockholders and eligible equity plan holders (28.7) (30.8) (28.9)
Net cash used in financing activities (74.0) (132.0) (98.9)
Net increase (decrease) in cash and cash equivalents (6.2) 1.1 (31.4)
Cash and cash equivalents at the beginning of the period 11.0 9.9 41.3
Cash and cash equivalents at the end of the period $ 4.8 $ 11.0 $ 9.9